|
Originally published In Press as doi:10.1074/jbc.M211424200 on December 11, 2002
J. Biol. Chem., Vol. 278, Issue 13, 11167-11174, March 28, 2003
Role of Cyclooxygenase 2 in Protein Kinase C II-mediated
Colon Carcinogenesis*
Wangsheng
Yu,
Nicole R.
Murray,
Capella
Weems,
Lu
Chen,
Huiping
Guo,
Richard
Ethridge,
Jeffrey D.
Ceci,
B. Mark
Evers,
E. Aubrey
Thompson, and
Alan P.
Fields
From the Sealy Center for Cancer Cell Biology and the Departments
of Pharmacology and Toxicology, Human Biological Chemistry and Genetics
and Surgery, The University of Texas Medical Branch, Galveston, Texas
77555-1048
Elevated expression of protein kinase C II
(PKC II) is an early promotive event in colon carcinogenesis
(Gokmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica,
Z., and Fields, A. P. (2001) Cancer Res. 61, 1375-1381). Expression of PKC II in the colon of transgenic mice
leads to hyperproliferation and increased susceptibility to colon
carcinogenesis due, at least in part, to repression of transforming
growth factor beta type II receptor (TGF- RII) expression (Murray,
N. R., Davidson, L. A., Chapkin, R. S., Gustafson,
W. C., Schattenberg, D. G., and Fields, A. P. (1999)
J. Cell Biol., 145, 699-711). Here we report that
PKC II induces the expression of cyclooxygenase type 2 (Cox-2) in rat intestinal epithelial (RIE) cells in vitro and in
transgenic PKC II mice in vivo. Cox-2 mRNA increases
more than 10-fold with corresponding increases in Cox-2 protein and
PGE2 production in RIE/PKC II cells. PKC II activates the Cox-2
promoter by 2- to 3-fold and stabilizes Cox-2 mRNA by at least
4-fold. The selective Cox-2 inhibitor Celecoxib restores expression of
TGF- RII both in vitro and in vivo and restores TGF -mediated transcription in RIE/PKC II cells. Likewise, the -3 fatty acid eicosapentaenoic acid (EPA), which inhibits PKC II activity and colon carcinogenesis, causes inhibition of Cox-2
protein expression, re-expression of TGF- RII, and restoration of
TGF- 1-mediated transcription in RIE/PKC II cells. Our data demonstrate that PKC II promotes colon cancer, at least in
part, through induction of Cox-2, suppression of TGF- signaling, and establishment of a TGF- -resistant, hyperproliferative state in the
colonic epithelium. Our data define a procarcinogenic PKC II Cox-2 TGF- signaling axis within the colonic epithelium, and
provide a molecular mechanism by which dietary -3 fatty acids and
nonsteroidal antiinflammatory agents such as Celecoxib suppress colon carcinogenesis.
*
This work was supported by grants from the National Cancer
Institute (to A. P. F.) (CA81436 and CA56869).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: The Sealy Center for
Cancer Cell Biology, The University of Texas Medical Branch, 301 University Blvd., MRB 9.104, Galveston, TX 77555-1048; Tel.: 409-747-1935; Fax: 409-747-1938; E-mail: afields@utmb.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Fields, S. R. Calcagno, M. Krishna, S. Rak, M. Leitges, and N. R. Murray
Protein Kinase C{beta} Is an Effective Target for Chemoprevention of Colon Cancer
Cancer Res.,
February 15, 2009;
69(4):
1643 - 1650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Lin, W.-C. Hou, S.-C. Shen, S.-H. Juan, C.-H. Ko, L.-M. Wang, and Y.-C. Chen
Quercetin inhibition of tumor invasion via suppressing PKC{delta}/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells
Carcinogenesis,
September 1, 2008;
29(9):
1807 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li and I. B. Weinstein
Protein Kinase C {beta} Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells
Cancer Res.,
December 1, 2006;
66(23):
11399 - 11408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Teicher
Protein kinase C as a therapeutic target.
Clin. Cancer Res.,
September 15, 2006;
12(18):
5336 - 5345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, K. Aonuma, I. Yamaguchi, and T. Miyauchi
Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta1 and phosphorylated JNK
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H835 - H845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakagawa, J. L. Oliva, D. Kothapalli, A. Fournier, R. K. Assoian, and M. G. Kazanietz
Phorbol Ester-induced G1 Phase Arrest Selectively Mediated by Protein Kinase C{delta}-dependent Induction of p21
J. Biol. Chem.,
October 7, 2005;
280(40):
33926 - 33934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields
Atypical Protein Kinase C{iota} Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity
J. Biol. Chem.,
September 2, 2005;
280(35):
31109 - 31115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujimori, K. Kadoyama, and Y. Urade
Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells
J. Biol. Chem.,
May 6, 2005;
280(18):
18452 - 18461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields
Protein Kinase C{beta}II Regulates Its Own Expression in Rat Intestinal Epithelial Cells and the Colonic Epithelium in Vivo
J. Biol. Chem.,
October 29, 2004;
279(44):
45556 - 45563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields
Protein Kinase C (PKC) {beta}II Induces Cell Invasion through a Ras/Mek-, PKC{iota}/Rac 1-dependent Signaling Pathway
J. Biol. Chem.,
May 21, 2004;
279(21):
22118 - 22123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Murray, L. Jamieson, W. Yu, J. Zhang, Y. Gokmen-Polar, D. Sier, P. Anastasiadis, Z. Gatalica, E. A. Thompson, and A. P. Fields
Protein kinase C{iota} is required for Ras transformation and colon carcinogenesis in vivo
J. Cell Biol.,
March 15, 2004;
164(6):
797 - 802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Gustafson, S. Ray, L. Jamieson, E. A. Thompson, A. R. Brasier, and A. P. Fields
Bcr-Abl Regulates Protein Kinase C{iota} (PKC{iota}) Transcription via an Elk1 Site in the PKC{iota} Promoter
J. Biol. Chem.,
March 5, 2004;
279(10):
9400 - 9408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wang, Y. Anini, W. Wei, X. Qi, A.-M. O'Carroll, T. Mochizuki, H.-Q. Wang, M. R. Hellmich, E. W. Englander, and G. H. Greeley Jr.
Apelin, a New Enteric Peptide: Localization in the Gastrointestinal Tract, Ontogeny, and Stimulation of Gastric Cell Proliferation and of Cholecystokinin Secretion
Endocrinology,
March 1, 2004;
145(3):
1342 - 1348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chen, A. Purohit, E. Halilovic, S. J. Doxsey, and A. C. Newton
Centrosomal Anchoring of Protein Kinase C {beta}II by Pericentrin Controls Microtubule Organization, Spindle Function, and Cytokinesis
J. Biol. Chem.,
February 6, 2004;
279(6):
4829 - 4839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Subbaramaiah, T. P. Marmo, D. A. Dixon, and A. J. Dannenberg
Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes: EVIDENCE FOR INVOLVEMENT OF p38, MAPKAPK-2, and HuR
J. Biol. Chem.,
September 26, 2003;
278(39):
37637 - 37647.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|